Health Technology Assessment: New Opportunity to Apply for Joint Scientific Consultations
The Commission has opened the first submission period for joint scientific consultations (JSCs) for 2026. JSCs enable health technology developers (pharma and medtech companies) to consult with the Health Technology Assessment agencies in the Member States on how their clinical studies should be conducted to best prepare for a potential Joint Clinical Assessment.
Read the e-News published by DG Health and Food Safety on 7 January 2026.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (16 février 2026). Health Technology Assessment: New Opportunity to Apply for Joint Scientific Consultations. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/15p1w





